GLOBAL CHEMOVET
GLOBAL CHEMOVET

CHEMOVET: Healthy Living for Your Pet

ONCOVET H (hidroxiurea)

Composition:

Oncovet® H: Hydroxyurea 100 mg. 
Oncovet® H: Hydroxyurea 250 mg. 
Oncovet® H: Hydroxyurea 500 mg. 


Strength:  
Oncovet® H, green coated tablets of 100 mg, 250 and 500 mg of Hydroxyurea, in individual cases with a non-toxic homopolymer polypropylene container, screen-printed, with a green RP-28 cap containing 30 tablets and a leaflet, in the following presentations:

 

Oncovet® H - Hydroxyurea 100 mg. - 1 bottle of 30 tablets per bottle.
Oncovet® H - Hydroxyurea 250 mg. - 1 bottle of 30 tablets per bottle.
Oncovet® H - Hydroxyurea 500 mg. - 1 bottle of 30 tablets per bottle.

Indication of use:

ONCOVET® H is indicated for the treatment of polycythemia vera, mast cell tumors and chronic myelogenous leukemia in canines and felines. ONCOVET® Hcould be of benefit in the treatment of feline hypereosinophilic syndrome and as an adjuvant treatment in canine meningiomas. It may also be used for adjunctive medical treatment (to reduce hematocrit) in dogs with right-to-left shunt ductus arteriosus or tetralogy of Fallot.

9 de Julio 3875, Lanús, Buenos Aires, Argentina

Contact: chemovet@chemovet.org

.

Connect 

Print | Sitemap
© Global Chemovet